BioPharmX Revenue 2011-2018 | BPMX

BioPharmX revenue from 2011 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
BioPharmX Annual Revenue
(Millions of US $)
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2012 $0
2011 $0
2011 $0
2010 $0
BioPharmX Quarterly Revenue
(Millions of US $)
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2018 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2017 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2016 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2015 $0
Q4 2014 $0
Q3 2014 $0
Q3 2014 $0
Q2 2014 $0
Q2 2014 $0
Q1 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $0
Q3 2011 $0
Q2 2011 $0
Q1 2011 $0
Q4 2010 $0
Q3 2010 $0
Q3 2010 $0
Q2 2010 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.026B $0.000B
BioPharmX Corporation is a specialty pharmaceutical company. The company focuses on the development of novel drug delivery products for women's health, dermatology and otolaryngology markets. The Company's product pipeline includes products in categories consists of prescription products, over-the-counter products and dietary supplements. Prescription products in development include molecular iodine pill for the treatment of breast pain associated with fibrocystic breast disease. OTC product pipeline includes a series of medicated bandages, nasal sprays and other products. Supplement product pipeline includes BioPharmX's breast health pill. Its product candidates include BPX03 a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia and BPX01 a non-lipophilic topical antibiotic for the treatment of acne. BioPharmX Corporation is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.737B 14.33
Gilead Sciences (GILD) United States $87.500B 10.54
Biogen (BIIB) United States $66.898B 13.55
Celgene (CELG) United States $61.045B 11.85
Vertex Pharmaceuticals (VRTX) United States $47.572B 83.10
Illumina (ILMN) United States $44.928B 52.33
Regeneron Pharmaceuticals (REGN) United States $43.775B 22.18
Alexion Pharmaceuticals (ALXN) United States $24.920B 17.05
BioMarin Pharmaceutical (BMRN) United States $17.042B 0.00
Incyte (INCY) United States $16.293B 450.35
Seattle Genetics (SGEN) United States $11.478B 0.00
Exact Sciences (EXAS) United States $9.214B 0.00
BeiGene (BGNE) Cayman Islands $8.366B 0.00
QIAGEN (QGEN) Netherlands $8.344B 26.69
Alnylam Pharmaceuticals (ALNY) United States $8.183B 0.00
Sarepta Therapeutics (SRPT) United States $7.969B 0.00
Exelixis (EXEL) United States $6.856B 19.43
Bluebird Bio (BLUE) United States $6.674B 0.00
Bio-Techne Corp (TECH) United States $6.055B 40.90
Amarin (AMRN) Ireland $5.364B 0.00
Moderna (MRNA) United States $5.349B 0.00
Galapagos (GLPG) Belgium $5.346B 0.00
Alkermes (ALKS) Ireland $5.218B 3358.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.720B 0.00
Horizon Pharma Public (HZNP) Ireland $3.674B 15.12
Array BioPharma (ARRY) United States $3.584B 0.00
Allogene Therapeutics (ALLO) United States $3.497B 0.00
Guardant Health (GH) United States $3.459B 0.00
Immunomedics (IMMU) United States $3.395B 0.00
Emergent Biosolutions (EBS) United States $3.317B 27.94
ARGENX SE-ADR (ARGX) Netherlands $3.288B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.088B 0.00
Blueprint Medicines (BPMC) United States $2.977B 0.00
Akcea Therapeutics (AKCA) United States $2.735B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.723B 0.00
China Biologic Products (CBPO) China $2.649B 18.86
Ultragenyx Pharmaceutical (RARE) United States $2.641B 0.00
Genomic Health (GHDX) United States $2.540B 85.76
Global Blood Therapeutics (GBT) United States $2.442B 0.00
Repligen (RGEN) United States $2.439B 76.16
Ligand Pharmaceuticals (LGND) United States $2.339B 17.89
Amicus Therapeutics (FOLD) United States $2.302B 0.00
Halozyme Therapeutics (HALO) United States $2.290B 51.10
Reata Pharmaceuticals (RETA) United States $2.174B 0.00
Arena Pharmaceuticals (ARNA) United States $2.153B 0.00
Myriad Genetics (MYGN) United States $2.110B 20.90
Mirati Therapeutics (MRTX) United States $2.031B 0.00
Denali Therapeutics (DNLI) United States $2.010B 0.00
Acceleron Pharma (XLRN) United States $1.977B 0.00
Innoviva (INVA) United States $1.963B 11.10
AnaptysBio (ANAB) United States $1.913B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.837B 0.00
MyoKardia (MYOK) United States $1.815B 0.00
Allakos (ALLK) United States $1.800B 0.00
Insmed (INSM) United States $1.791B 0.00
Atara Biotherapeutics (ATRA) United States $1.644B 0.00
Spark Therapeutics (ONCE) United States $1.643B 0.00
REGENXBIO (RGNX) United States $1.587B 21.28
Vanda Pharmaceuticals (VNDA) United States $1.582B 125.71
Zai Lab Unsponsored ADR (ZLAB) China $1.547B 0.00
Medicines (MDCO) United States $1.462B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.432B 0.00
NeoGenomics (NEO) United States $1.430B 117.69
Cambrex (CBM) United States $1.427B 10.65
Aimmune Therapeutics (AIMT) United States $1.378B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.326B 0.00
WAVE Life Sciences (WVE) Singapore $1.296B 0.00
Myovant Sciences (MYOV) United Kingdom $1.278B 0.00
Editas Medicine (EDIT) United States $1.256B 0.00
Clovis Oncology (CLVS) United States $1.198B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.197B 0.00
Rubius Therapeutics (RUBY) United States $1.182B 0.00
UniQure (QURE) Netherlands $1.161B 0.00
Sangamo Therapeutics (SGMO) United States $1.161B 0.00
Lion Biotechnologies (IOVA) United States $1.147B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.128B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.128B 0.00
Fate Therapeutics (FATE) United States $1.075B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.054B 0.00
Audentes Therapeutics (BOLD) United States $1.049B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.012B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.994B 0.00
Puma Biotechnology (PBYI) United States $0.966B 0.00
Solid Biosciences (SLDB) United States $0.946B 0.00
Retrophin (RTRX) United States $0.925B 0.00
Apellis Pharmaceuticals (APLS) United States $0.848B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.816B 0.00
InflaRx (IFRX) Germany $0.811B 0.00
Novavax (NVAX) United States $0.800B 0.00
Acorda Therapeutics (ACOR) United States $0.799B 10.12
Alder BioPharmaceuticals (ALDR) United States $0.796B 0.00
Athenex (ATNX) United States $0.795B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.790B 0.00
Coherus BioSciences (CHRS) United States $0.783B 0.00
Principia Biopharma (PRNB) United States $0.775B 0.00
Epizyme (EPZM) United States $0.763B 0.00
Vericel (VCEL) United States $0.760B 0.00
CytomX Therapeutics (CTMX) United States $0.759B 0.00
AC Immune SA (ACIU) Switzerland $0.757B 0.00
Dynavax Technologies (DVAX) United States $0.753B 0.00
G1 THERAPEUTICS (GTHX) United States $0.735B 0.00
Cellectis (CLLS) France $0.719B 0.00
Intra-Cellular Therapies (ITCI) United States $0.716B 0.00
UROGEN PHARMA (URGN) Israel $0.706B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.685B 0.00
Heska (HSKA) United States $0.683B 55.89
UNITY Biotechnology (UBX) $0.674B 0.00
Revance Therapeutics (RVNC) United States $0.670B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.669B 0.00
Twist Bioscience (TWST) United States $0.658B 0.00
Intellia Therapeutics (NTLA) United States $0.652B 0.00
RA PHARMCTL INC (RARX) United States $0.649B 0.00
ANI Pharmaceuticals (ANIP) United States $0.641B 12.27
Kura Oncology (KURA) United States $0.613B 0.00
Cara Therapeutics (CARA) United States $0.599B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.588B 0.00
Viking Therapeutics (VKTX) United States $0.572B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.572B 0.00
Arvinas (ARVN) United States $0.527B 0.00
Zymeworks (ZYME) Canada $0.521B 0.00
Osiris Therapeutics (OSIR) United States $0.504B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.501B 0.00
ObsEva SA (OBSV) Switzerland $0.494B 0.00
Anika Therapeutics (ANIK) United States $0.490B 20.29
Prothena (PRTA) Ireland $0.477B 0.00
Eidos Therapeutics (EIDX) United States $0.472B 0.00
Gritstone Oncology (GRTS) United States $0.470B 0.00
Inovio Pharmaceuticals (INO) United States $0.468B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.466B 0.00
Arcus Biosciences (RCUS) United States $0.461B 0.00
PDL BioPharma (PDLI) United States $0.454B 7.40
Mesoblast (MESO) Australia $0.454B 0.00
Zealand Pharma (ZEAL) Denmark $0.441B 4.86
Clementia Pharmaceuticals (CMTA) Canada $0.441B 0.00
DBV Technologies (DBVT) France $0.439B 0.00
Kezar Life Sciences (KZR) United States $0.428B 0.00
BeyondSpring (BYSI) United States $0.426B 0.00
Evelo Biosciences (EVLO) United States $0.413B 0.00
MediciNova (MNOV) United States $0.411B 0.00
Synthorx (THOR) United States $0.407B 0.00
Scholar Rock Holding (SRRK) United States $0.402B 0.00
Senesco Technologies (ELOX) United States $0.400B 0.00
Cytokineticsorporated (CYTK) United States $0.385B 0.00
Agenus (AGEN) United States $0.383B 0.00
Kindred Biosciences (KIN) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.368B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.360B 0.00
Five Prime Therapeutics (FPRX) United States $0.356B 0.00
Krystal Biotech (KRYS) United States $0.346B 0.00
Cellular Biomedicine (CBMG) United States $0.343B 0.00
Abeona Therapeutics (ABEO) United States $0.337B 0.00
Replimune (REPL) United States $0.332B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.330B 0.00
AVROBIO (AVRO) United States $0.328B 0.00
Stemline Therapeutics (STML) United States $0.320B 0.00
Enochian Biosciences (ENOB) United States $0.318B 0.00
Kodiak Sciences (KOD) United States $0.317B 0.00
Merus (MRUS) Netherlands $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.301B 0.00
BioDelivery Sciences (BDSI) United States $0.300B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.298B 0.00
MeiraGTx Holdings (MGTX) United States $0.294B 0.00
Urovant Sciences (UROV) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.290B 0.00
Sorrento Therapeutics (SRNE) United States $0.279B 0.00
Kadmon Holdings (KDMN) United States $0.276B 0.00
Intec Pharma (NTEC) Israel $0.268B 0.00
Gamida Cell (GMDA) Israel $0.266B 0.00
Liquidia Technologies (LQDA) United States $0.253B 0.00
Verastem (VSTM) United States $0.249B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.243B 0.00
Sutro Biopharma (STRO) United States $0.240B 0.00
Axsome Therapeutics (AXSM) United States $0.240B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.231B 0.00
Magenta Therapeutics (MGTA) United States $0.229B 0.00
ResTORbio (TORC) United States $0.227B 0.00
Celcuity (CELC) United States $0.226B 0.00
Aduro Biotech (ADRO) United States $0.222B 0.00
PSivida (EYPT) United States $0.220B 0.00
Syros Pharmaceuticals (SYRS) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.218B 0.00
Arbutus Biopharma (ABUS) Canada $0.216B 0.00
Kamada (KMDA) Israel $0.215B 19.74
Paratek Pharmaceuticals (PRTK) United States $0.212B 0.00
MannKind (MNKD) United States $0.212B 0.00
Celyad SA (CYAD) Belgium $0.212B 0.00
Kala Pharmaceuticals (KALA) United States $0.204B 0.00
Cerecor (CERC) United States $0.204B 0.00
XBiotech (XBIT) United States $0.204B 0.00
CorMedix Inc (CRMD) United States $0.203B 0.00
Geron (GERN) United States $0.203B 0.00
Adverum Biotechnologies (ADVM) United States $0.201B 0.00
Aptinyx (APTX) United States $0.200B 0.00
Athersys (ATHX) United States $0.200B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.194B 0.00
Synlogic (SYBX) United States $0.189B 0.00
Allena Pharmaceuticals (ALNA) United States $0.186B 0.00
ChromaDex (CDXC) United States $0.185B 0.00
Equillium (EQ) United States $0.184B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.182B 0.00
VBI Vaccines (VBIV) United States $0.180B 0.00
LogicBio Therapeutics (LOGC) United States $0.177B 0.00
Protagonist Therapeutics (PTGX) United States $0.176B 0.00
Cohbar (CWBR) United States $0.174B 0.00
TOCAGEN INC (TOCA) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.165B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.161B 0.00
ADMA Biologics Inc (ADMA) United States $0.158B 0.00
Compugen (CGEN) Israel $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Constellation Pharmaceuticals (CNST) United States $0.152B 0.00
Palatin Technologies (PTN) United States $0.146B 18.02
Spero Therapeutics (SPRO) United States $0.143B 0.00
Motif Bio Plc (MTFB) United States $0.141B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Menlo Therapeutics (MNLO) United States $0.135B 0.00
BioTime (BTX) United States $0.135B 0.00
Axovant Sciences (AXON) United Kingdom $0.135B 0.00
Organovo Holdings (ONVO) United States $0.130B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Pluristem Therapeutics (PSTI) Israel $0.129B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Cue Biopharma (CUE) United States $0.125B 0.00
Pfenex (PFNX) United States $0.124B 0.00
OvaScience (MLND) United States $0.122B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.118B 0.00
XOMA (XOMA) United States $0.118B 0.00
Proteostasis Therapeutics (PTI) United States $0.116B 0.00
VTv Therapeutics (VTVT) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.114B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Cocrystal Pharma (COCP) United States $0.111B 123.33
NantKwest (NK) United States $0.109B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
Signal Genetics (MGEN) United States $0.103B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.089B 0.00
Mustang Bio (MBIO) United States $0.089B 0.00
Mersana Therapeutics (MRSN) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Chiasma (CHMA) United States $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Anavex Life Sciences (AVXL) United States $0.086B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.085B 0.00
OVID THERAPEUTC (OVID) United States $0.084B 0.00
Cidara Therapeutics (CDTX) United States $0.084B 0.00
Cel-Sci (CVM) United States $0.084B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
ITUS (ANIX) United States $0.083B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
Provention Bio (PRVB) United States $0.079B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.071B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
ScPharmaceuticals (SCPH) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
AEterna Zentaris (AEZS) United States $0.059B 11.25
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Monster Digital (INNT) United States $0.058B 0.00
Eleven Biotherapeutics (SESN) United States $0.058B 0.00
Alimera Sciences (ALIM) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
Alcobra (ARCT) United States $0.055B 0.00
Evogene (EVGN) Israel $0.054B 0.00
Bellerophon Therapeutics (BLPH) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Adial Pharmaceuticals (ADIL) United States $0.050B 0.00
Proteon Therapeutics (PRTO) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.047B 0.00
Arsanis (ASNS) United States $0.047B 0.00
Selecta Biosciences (SELB) United States $0.046B 0.00
Trevena (TRVN) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.045B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
OncoSec Medical (ONCS) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Versartis (ARAV) United States $0.044B 3.83
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Asterias Biotherapeutics (AST) United States $0.042B 0.00
Celsion (CLSN) United States $0.040B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Clearside Biomedical (CLSD) United States $0.036B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.032B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.030B 4.88
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Oragenics (OGEN) United States $0.029B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
TRACON Pharmaceuticals (TCON) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
GTx (GTXI) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
Aileron Therapeutics (ALRN) United States $0.022B 0.00
CytRx (CYTR) United States $0.021B 0.00
Vical (VICL) United States $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Benitec Biopharma (BNTC) Australia $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Cellect Biotechnology (APOP) Israel $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Cleveland BioLabs (CBLI) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.37
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Pulmatrix (PULM) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Neuralstem (CUR) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00